Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group
Titel:
Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group
Auteur:
Joy, Melanie S. Gipson, Debbie S. Powell, Leslie MacHardy, Jacqueline Jennette, J. Charles Vento, Suzanne Pan, Cynthia Savin, Virginia Eddy, Allison Fogo, Agnes B. Kopp, Jeffrey B. Cattran, Daniel Trachtman, Howard